Antigen molecule against Dabigantran； method of manufacture； and side effects of excess dose events used in treatment or prevention of hemodilution therapy or hemodilution therapy.
VAN RYN JOANNE,LITZENBURGER TOBIAS,CANADA KEITH,COPENHAVER ROBERT,HAUEL NORBERT,SINGH SANJAYA,WATERMAN ALISA K,SARKO CHRISTOPHER RONALD
申请号：
CL2013002551
公开号：
CL2013002551A1
申请日:
2013.09.05
申请国别(地区):
CL
年份:
2014
代理人:
摘要：
The present invention relates to antibody molecules against anticoagulants, in particular dabigatran, and their use as antidotes of such anticoagulants.MOLECULA DE ANTICUERPO CONTRA DABIGATRAN； METODO DE FABRICACION； Y SU USO PARA TRATAR O PREVENIR LOS EFECTOS SECUNDARIOS DE LA TERAPIA CON ANTICOAGULANTES O DE UN EVENTO DE SOBREDOSIS EN LA TERAPIA CON ANTICOAGULANTES.
